Amy Ramser, MD
Dermatology · Staunton, VANPI 1881057073
Payments from drug & device makers
What this record shows
This record is dominated by grants: $32,069 of the $33,805 with a category attached, or 94.9%. Pfizer accounts for 94.9% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $32,210 and has fallen 98.8% since, to $383 in 2025. Among dermatology clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 45 payments — averaging $751.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$32K
- AbbVie$341
- Sun Pharmaceutical Industries Inc.$275
- Regeneron Healthcare Solutions, Inc.$252
- Lilly USA, LLC$148
- Genentech USA, Inc.$140
- plus $555 from 8 others
What the payments were for
- Grants$32,06995%
- Food & beverage$1,6285%
- Education$1070%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 2 | $32,092 |
| AbbVie | 15 | $341 |
| Sun Pharmaceutical Industries Inc. | 3 | $275 |
| Regeneron Healthcare Solutions, Inc. | 4 | $252 |
| Lilly USA, LLC | 4 | $148 |
| Genentech USA, Inc. | 2 | $140 |
| Galderma Laboratories, L.p. | 2 | $130 |
| E.r. Squibb & Sons, L.L.C. | 2 | $116 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $87 |
| Amgen | 3 | $69 |
| UCB, Inc. | 2 | $62 |
| Johnson & Johnson | 3 | $55 |
| Arcutis Biotherapeutics, Inc. | 1 | $18 |
| Novartis | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$33,805 in reported general payments places this provider in the 90th percentile of 396 dermatology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 37 | $3,044 |
| Clobetasol Propionate | 70 | $2,982 |
| Ketoconazole | 108 | $1,672 |
| Tretinoin | 15 | $1,159 |
| Ammonium Lactate | 33 | $845 |
| Ciclopirox | 22 | $832 |
| Nystatin | 48 | $731 |
| Triamcinolone Acetonide | 106 | $696 |
| Doxycycline Hyclate | 43 | $627 |
| Hydroxychloroquine Sulfate | 20 | $497 |
| Mupirocin | 64 | $453 |
| Clindamycin Phosphate | 16 | $386 |
| Hydrocortisone | 55 | $337 |
| ValacyclovirValacyclovir Hcl | 17 | $248 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Staunton
- Naiem IssaVienna$2M
- Saurabh SinghFairfax$1.7M
- Diego DasilvaVirginia Beach$1.1M
- Vishal PatelLeesburg$719K
- Cyndi Torosky TommasoVirginia Beach$717K
- Daniel HurdBlacksburg$545K
- Jonathan SchreiberNorfolk$330K
- Robert BaerSuffolk$303K
- David PariserNorfolk$261K
- Hema SundaramFairfax$181K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.